MktsMarkets

Erasca, Inc.
NASDAQ: ERASKey statistics
ERAS News
Stories mentioning ERAS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 187,911 | 32,604 | 34,546 | 38,125 | 35,630 | 35,712 | 37,242 | 67,782 |
| Operating Income (Loss) | (187,911) | (32,604) | (34,546) | (38,125) | (35,630) | (35,712) | (37,242) | (67,782) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 22.00 | (37.00) | (76.00) | 173.00 | ||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (183,440) | (29,092) | (30,612) | (33,876) | (30,966) | (32,232) | (31,200) | (63,201) |
| Earnings Per Share (Basic) | (0.60) | (0.10) | (0.11) | (0.12) | (0.11) | (0.14) | (0.11) | (0.29) |
| Earnings Per Share (Diluted) | (0.60) | (0.10) | (0.11) | (0.12) | (0.11) | (0.14) | (0.11) | (0.29) |
| Weighted Average Shares Outstanding (Basic) | 304,317 | 283,534 | 283,682 | 283,356 | 283,260 | 233,818 | 282,385 | 217,807 |
| Weighted Average Shares Outstanding (Diluted) | 304,317 | 283,534 | 283,682 | 283,356 | 283,260 | 233,818 | 282,385 | 217,807 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ERAS
Erasca, Inc. (NASDAQ: ERAS) is a stock listed on the Nasdaq Stock Market under the ticker symbol ERAS. It last traded at $14.39 (Oct 23, 2026, 9:30 AM ET), up 2.5% on the day. That gives Erasca a market capitalisation of $5.1B.
Over the past 52 weeks ERAS has traded between $2.10 and $24.28.
For the quarter ended Mar 31, 2026 it reported a net loss of $183.4M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$183.4M |
| Dec 31, 2025 | — | -$29.1M |
| Sep 30, 2025 | — | -$30.6M |
| Jun 30, 2025 | — | -$33.9M |
From Erasca’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…